TABLE 4.
OVerall prognostic model for OS.
| Characteristic | HR | 95% CI | p value |
|---|---|---|---|
| Age at diagnosis | |||
| Age <70 years | — | — | |
| Age ≥70 years | 0.73 | 0.66, 0.80 | <0.001 |
| Received SCT | 0.32 | 0.28, 0.37 | <0.001 |
| Practice type | |||
| Community | — | — | |
| Academic | 0.91 | 0.78, 1.06 | 0.2 |
| ECOG | |||
| 0 | — | — | |
| 1 | 1.43 | 1.22, 1.68 | <0.001 |
| 2+ | 2.17 | 1.82, 2.57 | <0.001 |
| Unknown/not documented | 1.54 | 1.33, 1.77 | <0.001 |
| ISS stage | |||
| Stage I | — | — | |
| Stage II | 1.64 | 1.38, 1.94 | <0.001 |
| Stage III | 2.28 | 1.94, 2.68 | <0.001 |
| Unknown/not documented | 2.28 | 1.97, 2.65 | <0.001 |
| High‐risk status | |||
| No | — | — | |
| Yes | 1.31 | 1.20, 1.44 | <0.001 |
| Year of diagnosis | |||
| 2011–2015 | — | — | |
| 2016–2019 | 0.95 | 0.86, 1.04 | 0.3 |
Abbreviations: CI, confidence interval; ECOG, Eastern Cooperative Oncology Group; HR, hazard ratio; ISS, International Staging System; OS, overall survival; SCT, stem cell transplant.